|
RAI14 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.333400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.082620E-01 |
| Normal-vs-Stage2 |
3.798800E-01 |
| Normal-vs-Stage3 |
8.131200E-01 |
| Normal-vs-Stage4 |
9.612800E-01 |
| Stage1-vs-Stage2 |
4.383900E-02 |
| Stage1-vs-Stage3 |
8.745700E-02 |
| Stage1-vs-Stage4 |
1.960150E-01 |
| Stage2-vs-Stage3 |
5.014400E-01 |
| Stage2-vs-Stage4 |
4.767600E-01 |
| Stage3-vs-Stage4 |
8.855600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.035000E-01 |
| Normal-vs-AfricanAmerican |
2.872200E-01 |
| Normal-vs-Asian |
5.689400E-01 |
| Caucasian-vs-AfricanAmerican |
1.048970E-01 |
| Caucasian-vs-Asian |
6.531000E-01 |
| AfricanAmerican-vs-Asian |
4.202000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.689000E-01 |
| Normal-vs-Female |
4.473200E-01 |
| Male-vs-Female |
6.392400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.917400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.862800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.737400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.452600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.024600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.096600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.712800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.950800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.364600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.031200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.420400E-02 |
| Normal-vs-Grade 2 |
6.478300E-02 |
| Normal-vs-Grade 3 |
5.505000E-01 |
| Normal-vs-Grade 4 |
7.023600E-01 |
| Grade 1-vs-Grade 2 |
1.620000E-01 |
| Grade 1-vs-Grade 3 |
1.594210E-02 |
| Grade 1-vs-Grade 4 |
7.660300E-02 |
| Grade 2-vs-Grade 3 |
7.237200E-03 |
| Grade 2-vs-Grade 4 |
1.133210E-01 |
| Grade 3-vs-Grade 4 |
9.916000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.011960E-02 |
| Normal-vs-ccB subtype |
6.334600E-01 |
| ccA subtype-vs-ccB subtype |
3.197100E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.916000E-01 |
| Normal-vs-N1 |
9.546200E-01 |
| N0-vs-N1 |
9.313000E-01 |
|
|
